v3.26.1
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Operating expenses:        
Research and development $ 1,819 $ 3,871 $ 1,933 $ 11,498
General and administrative 3,431 4,095 8,856 7,404
Acquired in-process research and development 0 0 22,180 0
Loss from operations (5,250) (7,966) (32,969) (18,902)
Other income (expense), net:        
Interest expense 0 (46) 0 (207)
Interest income and other income (expense), net 6 142 29 379
Total other income (expense), net 6 96 29 172
Provision for income taxes 0 0 0 0
Net loss $ (5,244) $ (7,870) $ (32,940) $ (18,730)
Net loss per share of common stock, RSUs and pre-funded warrants, basic $ (0.34) $ (2.07) $ (2.52) $ (5.17)
Net loss per share of common stock, RSUs and pre-funded warrants, diluted $ (0.34) $ (2.07) $ (2.52) $ (5.17)
Weighted-average shares of common stock, RSUs and pre-funded warrants outstanding, basic 15,223,972 3,802,956 13,089,640 3,621,329
Weighted-average shares of common stock, RSUs and pre-funded warrants outstanding, diluted 15,223,972 3,802,956 13,089,640 3,621,329